| Mitochondrial aspartate aminotransferase: a third kynurenate‐producing enzyme in the mammalian brain P Guidetti, L Amori, MT Sapko, E Okuno, R Schwarcz Journal of neurochemistry 102 (1), 103-111, 2007 | 198 | 2007 |
| Targeted deletion of the kynurenine aminotransferase II gene reveals a critical role of endogenous kynurenic acid in the regulation of synaptic transmission via α7 nicotinic … M Alkondon, EFR Pereira, P Yu, EZ Arruda, LEF Almeida, P Guidetti, ... Journal of Neuroscience 24 (19), 4635-4648, 2004 | 155 | 2004 |
| Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease MT Sapko, P Guidetti, P Yu, DA Tagle, R Pellicciari, R Schwarcz Experimental neurology 197 (1), 31-40, 2006 | 152 | 2006 |
| Biochemical and phenotypic abnormalities in kynurenine aminotransferase II-deficient mice P Yu, NA Di Prospero, MT Sapko, T Cai, A Chen, M Melendez-Ferro, F Du, ... Molecular and cellular biology, 2004 | 112 | 2004 |
| Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and meta-analysis SE Lakhan, MT Sapko International archives of medicine 2 (1), 1-8, 2009 | 102 | 2009 |
| Asymmetric synthesis and pharmacology of methylphenidate and its para-substituted derivatives DL Thai, MT Sapko, CT Reiter, DE Bierer, JM Perel Journal of medicinal chemistry 41 (4), 591-601, 1998 | 90 | 1998 |
| Economic evaluation in acupuncture: past and future M Jabbour, MT Sapko, DW Miller, LM Weiss, M Gross The American Acupuncturist 49, 11-7, 2009 | 17 | 2009 |
| NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute … A Nierenberg, P Lavin, DC Javitt, R Shelton, MT Sapko, S Mathew, ... International journal of bipolar disorders 11 (1), 28, 2023 | 10 | 2023 |
| NRX-101, a Rapid-Acting Anti-Depressant, Does Not Cause Neurotoxicity Following Ketamine Administration in Preclinical Models W Jordan, MT Sapko, R Siegel, J Javitt International Journal of Toxicology 42 (5), 379-385, 2023 | 2 | 2023 |
| D-cycloserine is not susceptible to self-administration using an intravenous self-administration model in male ketamine-habituated Sprague-Dawley rats MT Sapko, T Hanania, Q Chang, JC Javitt Pharmacology Biochemistry and Behavior 227, 173586, 2023 | 2 | 2023 |
| Real Time Quality Assurance of Depression Ratings in Psychiatric Clinical Trials M Korczykowski, M Sapko, C Colesare, I Sharpe, P Lavin, J Javitt Available at SSRN 4537055, 2023 | 1 | 2023 |
| NRX-101 (D-Cycloserine+ Lurasidone) Is Active against Drug-Resistant Urinary Pathogens In Vitro MT Sapko, M Manyak, R Panicucci, JC Javitt Antibiotics 13 (4), 308, 2024 | | 2024 |
| D-Cycloserine for the Treatment of Chronic Pain JC Javitt, MT Sapko Authorea Preprints, 2023 | | 2023 |
| D-CYCLOSERINE FOR THE TREATMENT OF CHRONIC PAIN MT Sapko, JC Javitt | | 2023 |
| International Journal of Bipolar Disorders A Nierenberg, P Lavin, DC Javitt, R Shelton, MT Sapko, S Mathew, ... | | 2023 |
| Endogenous kynurenic acid regulates alpha 7 nicotinic receptor activity and gabaergic synaptic transmission in the hippocampus EFR Pereira, M Alkondon, EZ Arruda, LEF Almeida, WP Fawcett, ... BIOPHYSICAL JOURNAL 86 (1), 541A-541A, 2004 | | 2004 |
| MAMMALIAN GENETIC MODELS WITH MINIMAL OR COMPLEX PHENOTYPES-Biochemical and Phenotypic Abnormalities in Kynurenine Aminotransferase II-Deficient Mice P Yu, NAD Prospero, MT Sapko, T Cai, A Chen, M Melendez-Ferro, F Du, ... Molecular and Cellular Biology 24 (16), 6919-6930, 2004 | | 2004 |
| A mouse without kynurenine aminotransferase II: Investigating the kynurenine pathway MT Sapko University of Maryland, Baltimore, 2004 | | 2004 |
| A mouse with reduced brain kynurenic acid shows increased susceptibilty to intrastriatal quinolinic acid MT Sapko, P Guidetti, P Yu, DA Tagle, R Schwarcz JOURNAL OF NEUROCHEMISTRY 85, 34-34, 2003 | | 2003 |
| S. 12.03 Physiological regulation of α7 nicotinic receptor activity by endogenous levels of the brain metabolite kynurenic acid: Clinical implications R Schwarcz, EFR Pereira, M Alkondon, LEF Almeida, WP Fawcett, ... European Neuropsychopharmacology, S128, 2003 | | 2003 |
